The present study aimed to both develop a thymic stroma‐independent T cell fraction with adiponectin‐expressing Tregs and investigate the efficacy of this fraction in suppressing tumor growth in an orthotopic 4 T1 TNBC model.13, 14. The gene discussed is ADIPOQ; the disease is neoplasm.